Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MCS compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name
MCS
Marcus Corp
Change
Mkt cap
Revenue
Revenue
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
MCS
Marcus Corp
vs
GMAB
Genmab A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MCS
0
None
Shared
0
No disclosed counterparties: MCS.
Only GMAB
1
COAG
Hemab Therapeutics
customer
Role chip = supplier or customer
Source: SEC EDGAR
MCS
Marcus Corp
Change
26.78
· pre 27.37
· delayed
Mkt cap
$829.5M
Revenue
$238M
Q3 FY26
Revenue
$758M
FY25
GMAB
Genmab A/S
Change
54.93
· pre 55.60
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$35.3B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 4 '26
delayed
MCS
Marcus Corp
vs
GMAB
Genmab A/S
26.78
pre 27.37
delayed
Price
54.93
pre 55.60
delayed
$829.5M
Mkt cap
$35.3B
Q3 FY26
$238M
Revenue
—
FY25
$758M
Revenue
—
Change
Change
MCS
26.78
vs
GMAB
54.93
Pre-market
Nov 4 '26
delayed